GLORIA BACCHUS: Open Payments
NPI 1598402752 · REIDSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 28 payments from 15 companies in 2025. Trend: 2023 $1,037 · 2024 $2,439 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $111 |
| Astellas Pharma US Inc | 5 | $92 |
| ABBVIE INC. | 5 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Exact Sciences Corporation | 2 | $41 |
| Novo Nordisk Inc | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $22 |
Products named: INCEPTIV, Veozah, CAPLYTA, VRAYLAR, Cologuard Collection Kit, QULIPTA, Kerendia, INVEGA SUSTENNA.
Industry payments across NC — which companies pay providers there.
